J30-8 is a potent and isoform-selective inhibitor of c-Jun N-terminal kinase 3 (JNK3) with an IC 50 of 40 nM, which 2500-fold isoform selectivity against JNK1α1 and JNK2α2. J30-8 exhibits neuroprotective activity in vitro and potential for the treatment of neurodegenerative diseasesForm:SolidIC50& Target:JNK3 40 nM (IC 50 ).
Specifications and Purity: ≥99%
Molecular Formula: C17H9ClFN3O2S
Molecular Weight: 373.79
PubChem CID: 4078145
Isomeric SMILES: C1=CC=C(C(=C1)NC2=NC(=C(S2)C3=C4C=C(C=CC4=NC3=O)F)O)Cl
- UPC:
- 41113641
- Condition:
- New
- HazmatClass:
- No
- WeightUOM:
- LB
- MPN:
- J651095-10mg
- CAS:
- 2366255-71-0
- Product Size:
- 10mg
akash.verma@cenmed.com
(732) 447-1115





